Fmoc-Asp-ODmb
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-Asp-ODmb

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fmoc-Amino Acids
Catalog number
BAT-015902
CAS number
155866-25-4
Molecular Formula
C28H27NO8
Molecular Weight
505.52
Fmoc-Asp-ODmb
IUPAC Name
(3S)-4-[(2,4-dimethoxyphenyl)methoxy]-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid
Synonyms
L-Aspartic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1-[(2,4-dimethoxyphenyl)methyl] ester; Fmoc-L-Aspartic acid alpha-2,4-dimethoxybenzyl ester
Density
1.303±0.06 g/cm3
Boiling Point
728.1±60.0 °C at 760 mmHg
Storage
Store at -20°C
InChI
InChI=1S/C28H27NO8/c1-34-18-12-11-17(25(13-18)35-2)15-36-27(32)24(14-26(30)31)29-28(33)37-16-23-21-9-5-3-7-19(21)20-8-4-6-10-22(20)23/h3-13,23-24H,14-16H2,1-2H3,(H,29,33)(H,30,31)/t24-/m0/s1
InChI Key
ODIFVCRSTRBDDR-DEOSSOPVSA-N
Canonical SMILES
COC1=CC(=C(C=C1)COC(=O)C(CC(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)OC

Fmoc-Asp-ODmb, a protected derivative of aspartic acid, utilized in peptide synthesis for diverse applications. Here are four key applications of Fmoc-Asp-ODmb presented with high perplexity and burstiness:

Peptide Drug Development: Widely utilized in peptide therapeutic synthesis, Fmoc-Asp-ODmb’s stability and ease of deprotection streamline the creation of bioactive peptides containing aspartic acid residues. This capability is pivotal in advancing novel peptide-based medications for ailments like diabetes and cancer, propelling the frontier of pharmaceutical innovation.

Biological Research: Within the realm of biological exploration, Fmoc-Asp-ODmb serves as a cornerstone for generating peptides employed in the analysis of protein-protein interactions and enzyme kinetics. These synthetic peptides, mimicking natural substrates or inhibitors, offer deep insights into molecular processes, enabling researchers to probe the functions and structures of proteins within diverse biological contexts with precision.

Structural Biology: A key component in structural biology, Fmoc-Asp-ODmb assumes a critical role in crafting peptidomimetics and synthetic peptides essential for crystallography and NMR investigations. These peptides are instrumental in uncovering the intricate three-dimensional configurations of proteins and protein complexes, laying the foundation for drug development and the identification of binding sites crucial for small molecule interactions.

Diagnostic Assays: In the realm of diagnostic assays, Fmoc-Asp-ODmb stands out for its role in synthesizing peptide-based probes utilized for detecting specific proteins or antibodies in biological samples, vital for disease diagnosis and monitoring. Peptides synthesized using Fmoc-Asp-ODmb are integral to assays like ELISA, enhancing sensitivity and specificity, pushing the boundaries of diagnostic precision and reliability.

1. Solid-Phase Total Synthesis of Bacitracin A
Jinho Lee, John H. Griffin, Thalia I. Nicas J Org Chem. 1996 Jun 14;61(12):3983-3986. doi: 10.1021/jo960580b.
An efficient solid-phase method for the total synthesis of bacitracin A is reported. This work was undertaken in order to provide a general means of probing the intriguing mode of action of the bacitracins and exploring their potential for use against emerging drug-resistant pathogens. The synthetic approach to bacitracin A involves three key features: (1) linkage to the solid support through the side chain of the L-asparaginyl residue at position 12 (L-Asn(12)), (2) cyclization through amide bond formation between the alpha-carboxyl of L-Asn(12) and the side chain amino group of L-Lys(8), and (3) postcyclization addition of the N-terminal thiazoline dipeptide as a single unit. To initiate the synthesis, Fmoc L-Asp(OH)-OAllyl was attached to a PAL resin. The chain of bacitracin A was elaborated in the C-to-N direction by sequential piperidine deprotection/HBTU-mediated coupling cycles with Fmoc D-Asp(OtBu)-OH, Fmoc L-His(Trt)-OH, Fmoc D-Phe-OH, Fmoc L-Ile-OH, Fmoc D-Orn(Boc)-OH, Fmoc L-Lys(Aloc)-OH, Fmoc L-Ile-OH, Fmoc D-Glu(OtBu)-OH, and Fmoc L-Leu-OH. The allyl ester and allyl carbamate protecting groups of L-Asn(12) and L-Lys(8), respectively, were simultaneously and selectively removed by treating the peptide-resin with palladium tetrakis(triphenylphosphine), acetic acid, and triethylamine. Cyclization was effected by PyBOP/HOBT under the pseudo high-dilution conditions afforded by attachment to the solid support. After removal of the N-terminal Fmoc group, the cyclized peptide was coupled with 2-[1'(S)-(tert-butyloxycarbonylamino)-2'(R)-methylbutyl]-4(R)-carboxy-Delta(2)-thiazoline (1). The synthetic peptide was deprotected and cleaved from the solid support under acidic conditions and then purified by reverse-phase HPLC. The synthetic material exhibited an ion in the FAB-MS at m/z 1422.7, consistent with the molecular weight calculated for the parent ion of bacitracin A (MH(+) = C(73)H(84)N(10)O(23)Cl(2), 1422.7 g/mol). It was also indistinguishable from authentic bacitracin A by high-field (1)H NMR and displayed antibacterial activity equal to that of the natural product, thus confirming its identity as bacitracin A. The overall yield for the solid-phase synthesis was 24%.
2. Solid-phase synthesis and applications of N-(S-acetylmercaptoacetyl) peptides
J W Drijfhout, W Bloemhoff, J T Poolman, P Hoogerhout Anal Biochem. 1990 Jun;187(2):349-54. doi: 10.1016/0003-2697(90)90468-o.
The reagent pentafluorophenyl S-acetylmercaptoacetate was used to modify the N-terminus of resin-bound side-chain-protected peptides. The modification was carried out in an automated cycle in the final stage of fluorenylmethoxycarbonyl (Fmoc)/polyamide-mediated solid-phase synthesis. Side-chain deprotection and cleavage from the resin with aqueous trifluoroacetic acid gave the N-(S-acetylmercaptoacetyl) peptides. The S-acetylmercaptoacetyl peptides were transformed into reactive thiol-containing peptides by incubation with hydroxylamine at neutral pH. The S-deacetylation was performed in the presence of a sulfhydryl-reactive compound (or intramolecular group) to enable immediate capture of the sensitive thiol. Three applications were investigated. An S-acetylmercaptoacetyl peptide, containing a sequence of a meningococcal membrane protein, was incubated with hydroxylamine in the presence of 5-(iodoacetamido)fluorescein to give the corresponding fluorescein-labeled peptide in 62% yield. The same peptide was also S-deacetylated in the presence of bromoacetylated poly-L-lysine to afford a peptide/polylysine conjugate. Finally, a peptide corresponding to a sequence of herpes simplex virus glycoprotein D was prepared. This peptide, containing an N-terminal-S-acetylmercaptoacetyl group and an additional C-terminal S-(3-nitro-2-pyridinesulfenyl)cysteine residue, was converted into a cyclic disulfide peptide (20%).
3. Asparagine coupling in Fmoc solid phase peptide synthesis
H Gausepohl, M Kraft, R W Frank Int J Pept Protein Res. 1989 Oct;34(4):287-94. doi: 10.1111/j.1399-3011.1989.tb01576.x.
To investigate side reactions during the activation of side chain unprotected asparagine in Fmoc-solid phase peptide synthesis the peptide Met-Lys-Asn-Val-Pro-Glu-Pro-Ser was synthesized using different coupling conditions for introduction of the asparagine residue. Asparagine was activated by DCC/HOBt, BOP (Castro's reagent) or introduced as the pentafluorophenyl ester. The resulting peptide products were analyzed by HPLC, mass spectrometry and Edman degradation. In the crude products varying amounts of beta-cyano alanine were found, which had been formed by dehydration of the side chain amide during carboxyl activation of Fmoc-asparagine. A homogeneous peptide was obtained by using either side chain protected asparagine derivatives with BOP mediated activation or by coupling of Fmoc-Asn-OPfp. Fmoc-Asn(Mbh)-OH and Fmoc-Asn(Tmob)-OH were coupled rapidly and without side reactions with BOP. For the side chain protected derivatives the coupling was as fast as that of other Fmoc-amino acid derivatives, whereas couplings of Fmoc-Asn-OH proceed more slowly. However, during acidolytic cleavage both protection groups, Mbh and Tmob, generate carbonium ions which readily alkylate tryptophan residues in a peptide. Tryptophan modification was examined using the model peptide Asn-Trp-Asn-Val-Pro-Glu-Pro-Ser. Alkylation could be reduced by addition of scavengers to the TFA during cleavage and side chain deprotection. A homogeneous peptide containing both, asparagine and tryptophan, was obtained only by coupling of Fmoc-Asn-OPfp.
Online Inquiry
Verification code
Inquiry Basket